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Introduction
Tissue plasminogen activator (tPA) increases the risk of cerebral hemorrhage after stroke, and the incidence of hyperglycemia (HG) further exacerbates this outcome [1] [2] [3] [4] . We have recently shown that the combination of HG and tPA exacerbates hemorrhagic transformation and worsens functional outcomes after stroke more than each of them alone [5] . However, the underlying mechanism through which this injury occurred was not known. We also showed that acute HG increased matrix metalloprotease 3 (MMP3) activity in the brain after stroke and this was associated with exacerbated cerebral hemorrhage and worse functional outcomes [6] . It was previously shown that MMP3, but not MMP9, plays a critical role in mediating the tPA-induced cerebral hemorrhage after stroke [7] . However, the impact of the interaction between HG and tPA on MMP3 activation after stroke, and the underlying mechanism through which HG-tPA induces MMP3 activation was not studied. Peroxynitrite is a potent oxidizing and nitrating agent that can cause lipid peroxidation and protein nitration and consequently can be involved in blood brain barrier (BBB) disruption. Peroxynitrite is increased in the brain after the ischemic injury and HG augments this effect [8, 9] . It was recently shown that peroxynitrite plays a role in MMP3 activation through tyrosine nitration in the synovial fluid of patients with temporomandibular joint (TMJ) disorders [10] . However, it is not known whether this is the mechanism through which MMP3 is activated in the brain in hyperglycemic stroke. Accordingly, this study was designed to test the hypothesis that: (1) the interaction between tPA and HG increases MMP3 activity in the brain after stroke; and (2) peroxynitrite-induced MMP3 nitration is the underlying mechanism of increased MMP3 activity in the brain in hyperglycemic stroke.
Materials and Methods
Animal Models and Study Groups
The animals were housed at the Augusta University animal care facility, which is approved by the American Association for Accreditation of Laboratory Animal Care. This study was conducted in accordance with the National Institute of Health guidelines for the care and use of animals in research and all protocols were approved by the institutional animal care and use committee. [11] . BMVEC were cultured in DMEM and incubated in hypoxic chamber under low oxygen tension for 3 h and then further cultured in DMEM with normal glucose (NG = 5 mM) or high glucose (HG = 25 mM) for 22.5 h to mimic the in vivo model. Study groups are: (1) normal glucose (NG); (2) NG + tPA; (3) high glucose (HG); (4) HG + tPA. Control cells were cultured in DMEM with normal or high glucose for 24 h under normoxia. tPA was added (10 µg/ml) at the end of 3 h hypoxia or normoxia. At the end of the incubation period (24 h), supernatant and cell lysates were collected separately and MMP3 activity was measured.
Study 2. Determine the role of peroxynitrite in activating MMP3 through tyrosine nitration in hyperglycemic stroke
Study 2.1. In vivo Brain homogenates from study 1.1 were analyzed for MMP3 nitration by immunoprecipitation.
Study 2.2.
In vitro BMVEC homogenates from study 1.2 were analyzed for MMP3 nitration. Furthermore, additional set of cells were subjected to oxygen glucose deprivation (OGD) for 6 h and treated with either tPA alone, FeTPPs (5,10,15,20-tetrakis(4-sulfonatophenyl) porphyrinato iron (III), chloride, 2.5 µg/ml) (peroxynitrite decomposition catalyst) alone or a combination of both tPA and FeTPPs. Treatments were added at the end of 6 h OGD, cells were harvested at 24 h and tested for MMP3 activity and MMP3 tyrosine nitration.
Stroke Surgery
Focal cerebral ischemia was performed as previously described [12] . Briefly, a midline cervical incision was made to expose the common carotid artery. The external carotid artery (ECA) was separated, ligated and cauterized. An arteriotomy was performed on the ECA stump. A rounded-tip 3 − 0 monofilament nylon suture (prepared carefully under microscope with high magnification power to ensure uniformity) was inserted into the ECA stump and advanced through the internal carotid artery to occlude the origin of MCA. For the embolic model, the surgical procedure remained the same as in suture model except that instead of the monofilament suture, a PE-10 catheter containing the clot was inserted through the ECA stump to deliver the clot to the origin of the MCA. Scanning laser Doppler (Pim-3, Perimed, ST) was used to confirm a similar degree of drop in CBF among groups. The percent drop in CBF after stroke was determined by comparing to baseline [13] . Animals with reduction in CBF less than 40% from baseline were excluded.
Preparation of Blood Clots
Fresh blood clots were prepared as we previously reported in details [5, 14, 15] .
Evaluation of MMP3 Enzymatic Activity
The enzymatic activity of MMP-3 was determined using a fluorescence resonance energy transfer (FRET) peptide and immunocapture assay as previously described elsewhere with minor modifications [16] . Briefly, 50 µg total protein of homogenized brain tissue were incubated at 4 °C for 2 h with rabbit polyclonal anti-MMP-3 antibody (Cat. No. sc-6839-R; Santa Cruz Biotechnology, Dallas, TX, USA). A/G agarose beads were then added and allowed to incubate overnight at 4 °C. The beads were then washed and samples are transferred to black 96 well plate and 100 µl of 2 mM 5-FAM/ QXL™520 FRET peptide (Cat. No. 60580-01; AnaSpec, San Jose, CA, USA) in assay buffer were added per well. Plates were incubated for 8 h at 37 °C and the relative fluorescence units (RFUs) were read and monitored at excitation/emission wavelengths of 485/528 nm in a Synergy HT Multi-mode microplate fluorescence reader (BioTek, Winooski, VT, USA) running Gen5™ data analysis software.
Immuno-Precipitation and Western Blotting
MMP3 nitration was evaluated by immuno-precipitation (IP) of either rats' brain homogenates or BMVEC lysates for MMP3 using anti-MMP3 antibody followed by western blotting against nitrated proteins using anti-nitrotyrosine antibody. Briefly, 100 µg protein from either brain homogenates or BMVEC lysates were incubated with anti-MMP3 antibody (Cat.No. sc-6839-R; Santa Cruz Biotechnology, Dallas, TX, USA) for 4 h at 4 °C. A/G agarose beads were then added and allowed to incubate overnight at 4 °C. On the next day, anti-MMP3-A/G protein complex was washed 2 times, precipitated by centrifugation and then analyzed by Western blotting using anti-nitrotyrosine antibody. 50 µl of 2 × loading buffer was added to the immune-precipitated protein-beads complex and boiled for 20 min then centrifuged and equal volumes of the supernatant (30 µl) were loaded and separated by 10% sodium dodecyl sulfate-polyacrylamide gel electrophoresis and transferred to nitrocellulose membrane. MMP3 nitration was determined by using anti-nitrotyrosine antibody (1:500) (05-233, Millipore, USA). Primary antibodies were detected using horseradish peroxidase-conjugated antibody and enhanced chemiluminescence. Band intensity was quantified by densitometry software (Alpha Innotech; Santa Clara, CA). Western blotting for MMP3 in BMVEC was done the same way using anti MMP3 antibody (1:500) (ab53015, Abcam, USA).
Statistical Analysis
The effect of hyperglycemia and tPA treatment on MMP3 activity was assessed using a 2 HG (no vs. yes) by 2 tPA (no vs. yes) ANOVA where a significant interaction would indicate a differential effect of tPA on MMP3 activity dependent on HG status. The effect of tPA on MMP3 activity in BMVEC compared to untreated cells was determined using a unpaired Student's t-test. The effect of HG on MMP3 tyrosine nitration (OD) compared to NG groups was determined using a student unpaired t-test. The effect of HG and hypoxia treatment on MMP3 tyrosine nitration in BMVEC was assessed using a 2 HG (no vs. yes) by 2 hypoxia (no vs. yes) ANOVA where a significant interaction would indicate a differential effect of hypoxia on MMP3 activity dependent on HG status. Effect of FeTTPs treatment was analyzed by one-way ANOVA within NG or HG groups. Statistical significance was determined at p < 0.05. Tukey's or Bonferroni post-hoc tests were used to compare means from significant one way or two-way ANOVAs, respectively.
Results
The Effect of HG and tPA on MMP3 Activity and Nitration In Vivo HG significantly increased MMP3 activity in ischemic hemisphere homogenates compared to NG animals. The administration of tPA significantly increased total brain MMP3 activity compared to non-treated animals. There was no interaction between HG and tPA interventions (Fig. 1a, b) . The HG-induced MMP3 activation was associated with significant increase in MMP3 tyrosine nitration in the brain after stroke, in rats subjected to either suture or thromboembolic occlusion (Fig. 2) .
The Effect of HG and tPA on MMP3 Activity and MMP3 Nitration In Vitro
The administration of tPA significantly increased MMP3 activity in BMVEC under normal or HG conditions, whether these cells were subjected to either normoxia or hypoxia. This effect was detected in both BMVEC lysate and supernatant (Fig. 3a, b) . High glucose or hypoxia alone significantly increased MMP3 expression (Fig. 4a ) and MMP3 nitration (Fig. 4b) in BMVECs. There was a treatment/intervention interaction such that hypoxia induced MMP3 expression in NG but not HG group (Fig. 4a) . On the other hand, hypoxia mediated nitrotyrosine formation in HG but not NG group (Fig. 4b) .
The Effect of Peroxynitrite Inhibition on MMP3 Activity
The use of tPA significantly increased MMP3 activity (Fig. 5a ) and MMP3 tyrosine nitration (Fig. 5b) in BMVECs subjected to OGD under either NG or HG conditions. The use of FeTPPs significantly reduced but not restored MMP3 activity (Fig. 5a) , although FeTTPs treatment almost completely prevented nitrotyrosine formation (Fig. 5b) . 
Discussion
Matrix metalloproteases, especially MMP2 and MMP9, play a major role in mediating HT after stroke through degradation of the tight junction proteins and disruption of the BBB [17] . MMP3 is a zinc endopeptidase that has a broad substrate specificity and can target and degrade all the component of the neurovascular unit [18] . It was previously shown that MMP3 plays a critical role in mediating the tPA induced intracranial bleeding in mice after stroke [7] . We recently showed that the HG-induced MMP3 activation exacerbated the hemorrhagic transformation and worsened the functional outcomes after stroke [6] . However, it was not known how MMP3 gets activated in hyperglycemic stroke. Furthermore, we also showed in an earlier study that the interaction between tPA and HG significantly increased HT and worsened stroke outcomes [5] , but the underlying mechanism was not known. So, in order to connect all the threads together, this study was designed to test the hypothesis that; 1-the interaction between HG and tPA increases MMP3 activity after stroke, and 2-MMP3 activation is mediated through peroxynitrite induced MMP3 tyrosine nitration.
Current findings show that either HG or tPA alone increases MMP3 activity in the brains of rats subjected to either suture or embolic occlusion. While the effect of the combination of HG and tPA on MMP3 activity is not synergistic, both interventions significantly affected MMP3 expression and activity. Correlating this to our previous findings, we propose that MMP3 plays an important role in mediating the HG-tPA induced HT and worse functional outcomes after stroke. We found that administration of tPA increased the activity of MMP3 in BMVECs isolated from rat brain, whether these cells were cultured under normal or high glucose conditions, subjected to either normoxia or hypoxia. However, in contrast to our hypothesis and in vivo findings, we did not see a further increase in MMP3 activity with hypoxia or high glucose alone in BMVECs. This may be because the insult was not strong enough to trigger this effect, as we subjected the cells to only 3 h of hypoxia and cultured in high glucose for only 18 h. In 2009, Suzuki et al. showed that administration of tPA has increased the production of MMP3 in brain endothelial cells derived from mouse brain subjected to 6 h of OGD. This effect was not seen when the cells were subjected to only 3 h of OGD [19] . However, when we further subjected the cells to 6 h of OGD, we still did not see an increase in MMP3 activity with high glucose compared to normal glucose. It is possibly that we either did not achieve the hypoxia threshold necessary to trigger MMP3 activation, or the elevated MMP3 activity that we see in total brain homogenates is a result of upregulation of endogenous in vivo enzymatic activity that is not available in the cultured endothelial cells and requires interaction of other cell types. This can also explain why we have seen an increase in MMP3 protein expression that was not associated with an increase in activity. Other explanation may be that endogenous MMPs inhibitors, like tissue inhibitors of metalloproteases (TIMPs), were suppressed or restrained in the brain environment, which was not the case in the cell culture system.
The underlying mechanisms through which HG worsens the neurovascular injury after stroke were always attributed to the HG-induced production of reactive oxygen/nitrogen species, especially superoxide anions and peroxynitrite [8] . Given that HG and stroke increase oxidative stress, we hypothesized that peroxynitrite may be increasing MMP3 activity in hyperglycemic stroke through induced tyrosine nitration. In 2009, Fujita et al. showed that MMP3 activation takes place through tyrosine nitration in the synovial fluid of patients with TMJ disorders, and thus leading to the pathophysiological progression of the internal derangement (ID) of TMJ [10] . Our immuno-precipitation studies showed that HG increased MMP3 nitration in the brains of rats subjected to either suture or thromboembolic occlusion. This increase in MMP3 tyrosine nitration corresponded to an increase in MMP3 activity. However, this was not the case in BMVECs, as cells subjected to hypoxia combined with high glucose showed an increase in MMP3 expression and MMP3 tyrosine nitration without a corresponding increase in activity. These findings show that tyrosine nitration may be one but not the only underlying mechanism causing MMP3 activation in hyperglycemic stroke. This is further supported by our in vivo data in which the combination effect was not synergistic suggesting that there may be more than one mechanism involved. The administration of tPA has significantly increased the activity of MMP3 in BMVECs and this corresponded to significant increase in MMP3 tyrosine nitration. Interestingly, the use of the peroxynitrite decomposition catalyst, FeTPPs, has significantly reduced MMP3 tyrosine nitration and MMP3 activity, further supporting our hypothesis that peroxynitrite-mediated nitration contributes to MMP3 activation. By the same token, the fact that MMP3 activity is not completely restored with FeTPPs suggests that additional mechanisms other than tyrosine nitration are involved in MMP3 activation. Previously we showed that FeTPPs administration at reperfusion significantly reduced MMP9 activity in Goto-Kakizaki diabetic rats and this was associated with reduced HT [20] . This raises the question for further future investigations, whether FeTPPs or a nitration inhibitor given at reperfusion would prevent MMP3 activation and improve outcomes in hyperglycemic stroke.
In conclusion, this study is novel to show that augmented MMP3 activity in the brain especially under HG conditions or with tPA treatment involves peroxynitrite-induced tyrosine nitration. In correlation with our previous findings, this identifies peroxynitrite and MMP3 as critical mediators of the HG-tPA induced HT, and points them out as potential therapeutic targets in hyperglycemic stroke.
